These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6608981)

  • 21. Cerebral glucose metabolism in Parkinson's disease with and without dementia.
    Peppard RF; Martin WR; Carr GD; Grochowski E; Schulzer M; Guttman M; McGeer PL; Phillips AG; Tsui JK; Calne DB
    Arch Neurol; 1992 Dec; 49(12):1262-8. PubMed ID: 1449406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease.
    Broussolle E; Cinotti L; Pollak P; Landais P; Le Bars D; Galy G; Lavenne F; Khalfallah Y; Chazot G; Mauguière F
    Mov Disord; 1993 Oct; 8(4):459-62. PubMed ID: 8232355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of partial volume correction on estimates of the influx and cerebral metabolism of 6-[(18)F]fluoro-L-dopa studied with PET in normal control and Parkinson's disease subjects.
    Rousset OG; Deep P; Kuwabara H; Evans AC; Gjedde AH; Cumming P
    Synapse; 2000 Aug; 37(2):81-9. PubMed ID: 10881028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Motor correlates of occipital glucose hypometabolism in Parkinson's disease without dementia.
    Bohnen NI; Minoshima S; Giordani B; Frey KA; Kuhl DE
    Neurology; 1999 Feb; 52(3):541-6. PubMed ID: 10025784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of bilateral subthalamic nucleus stimulation on resting-state cerebral glucose metabolism in advanced Parkinson's disease.
    Zhao YB; Sun BM; Li DY; Wang QS
    Chin Med J (Engl); 2004 Sep; 117(9):1304-8. PubMed ID: 15377418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in network activity with the progression of Parkinson's disease.
    Huang C; Tang C; Feigin A; Lesser M; Ma Y; Pourfar M; Dhawan V; Eidelberg D
    Brain; 2007 Jul; 130(Pt 7):1834-46. PubMed ID: 17470495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glucose metabolism and blood flow studies in 2 cases with juvenile Parkinson's disease].
    Shibasaki T
    Nihon Rinsho; 1997 Jan; 55(1):95-100. PubMed ID: 9014429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease.
    Mouatt-Prigent A; Karlsson JO; Yelnik J; Agid Y; Hirsch EC
    J Comp Neurol; 2000 Apr; 419(2):175-92. PubMed ID: 10722997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson's disease evaluated with multimodal MRI.
    Perlbarg V; Lambert J; Butler B; Felfli M; Valabrègue R; Privat AL; Lehéricy S; Petiet A
    PLoS One; 2018; 13(9):e0202597. PubMed ID: 30188909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing.
    Moeller JR; Eidelberg D
    Brain; 1997 Dec; 120 ( Pt 12)():2197-206. PubMed ID: 9448575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
    Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
    Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
    Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease.
    Mayberg HS; Starkstein SE; Sadzot B; Preziosi T; Andrezejewski PL; Dannals RF; Wagner HN; Robinson RG
    Ann Neurol; 1990 Jul; 28(1):57-64. PubMed ID: 2375634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral glucose and dopa metabolism in movement disorders.
    Martin WR; Hayden MR
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):448-51. PubMed ID: 2960430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perfusion and metabolism imaging studies in Parkinson's disease.
    Borghammer P
    Dan Med J; 2012 Jun; 59(6):B4466. PubMed ID: 22677251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
    Otsuka M; Ichiya Y; Hosokawa S; Kuwabara Y; Tahara T; Fukumura T; Kato M; Masuda K; Goto I
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease: metabolic and pharmacological approaches with positron emission tomography.
    Raichle ME; Perlmutter JS; Fox PT
    Ann Neurol; 1984; 15 Suppl():S131-2. PubMed ID: 6611113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.